What is Opus Genetics's D&A?

Opus Genetics (IRD) reported D&A of $13K in Q1 2026.

How has Opus Genetics's D&A changed year-over-year?

Opus Genetics's D&A decreased by 0.0% year-over-year, from $13K to $13K.

What is the long-term trend for Opus Genetics's D&A?

Over 4 years (2021 to 2025), Opus Genetics's D&A has grown at a 90.8% compound annual growth rate (CAGR), from $4K to $53K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Opus Genetics IRD D&A

D&A at other companies

MeiraGTx Holdings plcMGTX

$3.01M-2.4%

4D Molecular TherapeuticsFDMT

$1.27M+20.7%

Opko HealthOPK

$22.2M-5.5%

Kodiak Sciences IncKOD

$4.11M-10.7%

Regeneron PharmaceuticalsREGN

$123.2M-2.9%

RegenxbioRGNX

$3.86M-2.5%

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's D&A?: Opus Genetics (IRD) reported D&A of $13K in Q1 2026.
How has Opus Genetics's D&A changed year-over-year?: Opus Genetics's D&A decreased by 0.0% year-over-year, from $13K to $13K.
What is the long-term trend for Opus Genetics's D&A?: Over 4 years (2021 to 2025), Opus Genetics's D&A has grown at a 90.8% compound annual growth rate (CAGR), from $4K to $53K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.